Diagnostic and therapy of the complex regional pain syndrome
Our scientific studies of biological samples derived from CRPS patients demonstrated for the first time that the onset of CRPS is caused by autoantibodies against specific receptors, which activate these receptors and elicit, in the context of an autoimmune disease, neuronal inflammatory reactions. <br>
Specific ligands a patent is applied for are now provided. The ligands interact with these autoantibodies in the blood, thereby neutralizing them considerably. Bound for example to column material, the specific ligands can be employed for the therapy as well as the diagnosis of the complex regional pain syndrome, and even be used for prophylaxis.<br> As standard technology for diagnosis, in particular immunofluorescence has proven to be of value. In general, also other applications are possible.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…
